Verified email-pattern data for Gloria Biosciences is currently limited. You can still use the company insights and contact sections below.
Gloria Biosciences (誉衡生物) is a commercial stage biopharma company founded in 2016, bringing together a seasoned development and management team with global versions, and dedications to developing patient-centered treatments.
In 2021, Gloria Bio has successfully launched and commercialized a novel, fully human anti-PD-1 mAb, zimberelimab ("Yutuo", "誉拓”), for the treatment of relapsed or refractory classical Hodgkin’s lymphoma, which demonstrated an overall response rate (ORR) of 92.86%, DCR of 96.43%, and 12 month overall survival rate of 99% with improved long-term survival benefits for patients. Zimberelimab is also designated as Breakthrough Therapy by China's Center for Drug Evaluation for the treatment of recurrent or metastatic cervical cancer, which has been approved in July 2023, marking the first and only PD-1 mAb approved in China for cervical cancer, and third globally.
Currently, zimberelimab is being evaluated in multiple types of cancer, including prostate, colorectal, non-small cell lung, pancreatic, triple-negative breast, head and neck, and renal cell cancers, etc. It is also being studied in combinations with multiple innovative drugs, targeting CD47, CD73, TIGIT, A2aR, CCR8, LAG-3, CD40, CD39, Trop-2, CAR-T, HER-2 ACD and Neo-T, etc.
Gloria Biosciences is striving to build a pipeline with more effective treatment alternative for cancer patients, including LAG-3 and other innovative monoclonal and biospecific antibodies.
Company Details
- Employees
- 3
- Founded
- -
- Address
- The New Bund World Trade Center Phase 3, Tower A,#1602,china
- Industry
- Pharmaceutical Manufacturing
- Website
- https://www.gloriabio.com/
- Keywords
- Antibody, Pharmaceuticals, Oncology, Biotech, PD-1.
- HQ
- Shanghai
Gloria Biosciences Questions
Gloria Biosciences's website is https://www.gloriabio.com/
Gloria Biosciences's LinkedIn profile is https://cn.linkedin.com/company/gloriabio
Gloria Biosciences has
3 employees.
View email and phone details for 3
employees at Gloria Biosciences.
Gloria Biosciences's industry is
Pharmaceutical Manufacturing
Gloria Biosciences's top competitors are
Genscript,
和誉医药,
Genfleet Therapeutics,
Anticancer Bioscience,
Asieris Pharmaceuticals,
Henlius,
Innocare Pharma,
Sciclone Pharmaceuticals,
Ionova Life Science,
Sunho (China) Biopharmaceutical Co., Ltd..
Gloria Biosciences's categories are Pharmaceutical Manufacturing
Gloria Biosciences's founding year is 2016
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.